CME and Nasdaq Extend Nasdaq-100 Futures License

CME Group and Nasdaq announced a ten-year extension of CME Group’s exclusive license to offer futures and options on futures based on the Nasdaq-100 and other Nasdaq indexes, through 2039. “Extending our exclusive licensing agreement with Nasdaq will ensure that global market participants continue to have seamless access to our deeply liquid Nasdaq futures and options on futures, which are among the world’s most actively traded financial products,” said CME Group Chairman and Chief Executive Officer Terry Duffy. “Building on nearly 30 years of success, our partnership has enabled clients to manage risk or gain exposure to the 100 largest non-financial companies listed on Nasdaq, while providing significant capital efficiencies for those trading across our equity index complex.” “The Nasdaq-100 Index® is a cornerstone of modern investing, reflecting the performance of companies at the forefront of innovation and economic transformation. For almost 30 years, our partnership with CME Group has helped build a robust derivatives ecosystem that supports investor confidence and market integrity. This ten-year extension reflects our shared commitment to delivering enduring value through trusted benchmark products, reinforcing the infrastructure that enables global participation in the equity markets,” said Adena Friedman, Chair and CEO of Nasdaq. Nasdaq-100 futures were initially launched in 1996. In 1999, CME Group launched E-mini Nasdaq-100 futures, which have become one of the world’s most actively traded equity index futures contracts, with more than 2.8 billion contracts traded.